While the facial assessment is a key feature of Painchek technology, it is not meant to replace all other forms of assessment. The manual assessments are still necessary for a comprehensive evaluation of pain in non-verbal patients. Painchek technology is designed to augment and assist in the assessment process, not to replace it entirely. Additionally, the clinical trial you mentioned was conducted to compare the accuracy of Painchek with the existing standard, which includes the manual assessments. Overall, the use of Painchek technology can help healthcare professionals make more informed decisions and improve patient outcomes.
- Forums
- ASX - By Stock
- PCK
- Media Thread
Media Thread, page-960
-
-
- There are more pages in this discussion • 853 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.39M |
Open | High | Low | Value | Volume |
3.2¢ | 3.2¢ | 3.2¢ | $5.469K | 170.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 44930 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 108791 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 44930 | 0.032 |
3 | 287786 | 0.031 |
2 | 250000 | 0.030 |
2 | 350000 | 0.029 |
2 | 300000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 108791 | 1 |
0.035 | 345000 | 3 |
0.036 | 602857 | 5 |
0.037 | 20000 | 1 |
0.038 | 20000 | 1 |
Last trade - 14.22pm 06/11/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |